Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Receivables (2020 - 2025)

iSpecimen has reported Receivables over the past 6 years, most recently at $48298.0 for Q4 2025.

  • Quarterly results put Receivables at $48298.0 for Q4 2025, down 96.66% from a year ago — trailing twelve months through Dec 2025 was $48298.0 (down 96.66% YoY), and the annual figure for FY2025 was $48298.0, down 96.66%.
  • Receivables for Q4 2025 was $48298.0 at iSpecimen, down from $120931.0 in the prior quarter.
  • Over the last five years, Receivables for ISPC hit a ceiling of $4.7 million in Q4 2021 and a floor of $48298.0 in Q4 2025.
  • Median Receivables over the past 5 years was $2.9 million (2022), compared with a mean of $2.6 million.
  • Biggest five-year swings in Receivables: surged 117.58% in 2021 and later plummeted 96.66% in 2025.
  • iSpecimen's Receivables stood at $4.7 million in 2021, then fell by 17.2% to $3.9 million in 2022, then fell by 25.09% to $2.9 million in 2023, then crashed by 50.88% to $1.4 million in 2024, then plummeted by 96.66% to $48298.0 in 2025.
  • The last three reported values for Receivables were $48298.0 (Q4 2025), $120931.0 (Q3 2025), and $372469.0 (Q2 2025) per Business Quant data.